Israel Englander Morpho Sys Ag Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.6 - $18.18 $2.75 Million - $5.81 Million	-319,487 Reduced 96.84%	10,414 $188,000
Q4 2023 Feb 14, 2024	SELL	$4.55 - $9.9 $425,516 - $925,848	-93,520 Reduced 22.09%	329,901 $3.27 Million
Q2 2023 Aug 14, 2023	SELL	$3.95 - $7.74 $2.37 Million - $4.64 Million	-599,412 Reduced 58.6%	423,421 $3.16 Million
Q1 2023 May 15, 2023	BUY	$3.56 - $5.22 $709,159 - $1.04 Million	199,202 Added 24.19%	1,022,833 $4.04 Million
Q4 2022 Feb 14, 2023	SELL	$3.21 - $5.74 $416,895 - $745,476	-129,874 Reduced 13.62%	823,631 $2.95 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $22.13 $168,121 - $898,677	40,609 Added 4.45%	953,505 $4.8 Million
Q2 2022 Aug 15, 2022	SELL	$4.51 - $7.39 $504,754 - $827,081	-111,919 Reduced 10.92%	912,896 $4.42 Million
Q1 2022 May 16, 2022	BUY	$5.87 - $9.73 $2.73 Million - $4.52 Million	464,530 Added 82.91%	1,024,815 $6.95 Million
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $1.49 Million - $2.05 Million	164,446 Added 41.54%	560,285 $5.28 Million
Q3 2021 Nov 15, 2021	BUY	$11.76 - $19.51 $813,886 - $1.35 Million	69,208 Added 21.19%	395,839 $4.66 Million
Q2 2021 Aug 16, 2021	BUY	$18.95 - $23.95 $2.62 Million - $3.32 Million	138,433 Added 73.56%	326,631 $6.29 Million
Q1 2021 May 17, 2021	BUY	$21.56 - $30.66 $154,736 - $220,046	7,177 Added 3.96%	188,198 $4.1 Million
Q4 2020 Feb 16, 2021	SELL	$24.81 - $30.33 $2.18 Million - $2.67 Million	-88,066 Reduced 32.73%	181,021 $5.13 Million
Q3 2020 Nov 16, 2020	BUY	$30.28 - $35.72 $7.79 Million - $9.19 Million	257,210 Added 2165.61%	269,087 $8.45 Million
Q2 2020 Aug 14, 2020	SELL	$24.08 - $33.35 $511,266 - $708,087	-21,232 Reduced 64.13%	11,877 $376,000
Q1 2020 May 14, 2020	BUY	$18.86 - $37.36 $331,992 - $657,648	17,603 Added 113.52%	33,109 $813,000
Q4 2019 Feb 14, 2020	SELL	$26.07 - $36.32 $1.35 Million - $1.88 Million	-51,860 Reduced 76.98%	15,506 $553,000
Q3 2019 Nov 14, 2019	SELL	$24.18 - $31.58 $469,382 - $613,030	-19,412 Reduced 22.37%	67,366 $1.85 Million
Q2 2019 Aug 15, 2019	BUY	$23.24 - $26.76 $75,925 - $87,424	3,267 Added 3.91%	86,778 $2.1 Million
Q2 2019 Aug 14, 2019	SELL	$23.24 - $26.76 $2.35 Million - $2.71 Million	-101,204 Reduced 54.79%	83,511 $10.6 Million
Q1 2019 May 14, 2019	BUY	$22.55 - $29.84 $192,554 - $254,803	8,539 Added 4.85%	184,715 $4.19 Million
Q4 2018 Feb 14, 2019	SELL	$21.96 - $31.02 $2.88 Million - $4.07 Million	-131,358 Reduced 42.71%	176,176 $4.45 Million
Q3 2018 Nov 14, 2018	SELL	$26.64 - $35.66 $654,704 - $876,380	-24,576 Reduced 7.4%	307,534 $8.21 Million
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $8.35 Million - $10.2 Million	332,110 New	332,110 $10.1 Million

Others Institutions Holding MOR

# of Institutions

Shares Held

1.8M

Call Options Held

Put Options Held

14.7K

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account